| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |